There are 3163 resources available
Risk of gonadal toxicities with anticancer therapies with a focus on newer treatments
Presenter: Isabelle Demeestere
Session: Oncofertility: What every HCP involved in cancer care should know
Resources:
Slides
Webcast
Introduction
Presenter: Jayne Wood
Session: 9th ESMO Designated Centres of Integrated Oncology and Palliative Care session and awards: Specific considerations for integration of oncology and palliative care
Resources:
Slides
Webcast
Novel data in the field of immune checkpoint blockade for eTNBC
Presenter: Sara Tolaney
Session: The rapidly changing treatment landscape of early triple negative breast cancer
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Leslie Ballas
Session: Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?
Resources:
Slides
Webcast
1926MO - Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients treated with lenvatinib monotherapy: Real-world treatment patterns and clinical outcomes in Europe and Canada
Presenter: Laura Locati
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
LBA39 - Updated efficacy and safety data from IMbrave050: Phase III study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)
Presenter: Adam Yopp
Session: Proffered paper session 1: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
612O - Preliminary results from a phase I study of CFT1946, a novel BIDAC degrader in mutant BRAF V600 solid tumors
Presenter: Maria Vieito
Session: Proffered paper session 1: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
989O - Novel gene therapy in advanced solid malignancies: A phase I/II clinical trial
Presenter: Angelica Loskog
Session: Proffered paper session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1720MO - A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
Presenter: Evan Rosenbaum
Session: Mini oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
340O - Efficacy, safety and biomarker analysis of ICARUS-BREAST01: A phase II study of patritumab deruxtecan (HER3-DXd) in patients (pts) with HR+/HER2- advanced breast cancer (ABC)
Presenter: Barbara Pistilli
Session: Proffered paper session: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast